Stay updated on ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page.

Latest updates to the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page
- Check5 days agoChange DetectedSite revision notes updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices about government funding and operating status (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding status notice; updated the page version to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision on the page changed from v3.3.3 to v3.3.4, indicating a minor update to the page version.SummaryDifference0.0%

- Check84 days agoChange Detected- Added a comprehensive Locations section listing study sites by state (California, Connecticut, Florida, Illinois, Kentucky, Maryland, Michigan, Nebraska, New York, Ohio, Oklahoma, Tennessee, Wisconsin) and a Revision: v3.3.3.SummaryDifference1%

Stay in the know with updates to ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page.